1. 2022
  2. Factors Associated With Using the COVID-19 Mobile Contact-Tracing App Among Individuals Diagnosed With SARS-CoV-2 in Amsterdam, the Netherlands: Observational Study

    Ritsema, F., Bosdriesz, J. R., Leenstra, T., Petrignani, M. W. F., Coyer, L., Schreijer, A. J. M., van Duijnhoven, Y. T. H. P., van de Wijgert, J. H. H. M., van der Loeff, M. F. S. & Matser, A., 1 Aug 2022, In: JMIR mHealth and uHealth. 10, 8, e31099.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Who is providing HIV diagnostic testing? Comparing HIV testing by general practitioners and sexual health centres in five regions in the Netherlands, 2011-2018

    Bogers, S. J., Twisk, D. E., Beckers, L. M., Götz, H. M., Meima, B., Kroone, M., Hoornenborg, E., Ott, A., Luning-Koster, M. N., Dukers-Muijrers, N. H. T. M., Hoebe, C. J. P. A., Kampman, C. J. G., Bosma, F., Schim van der Loeff, M., Geerlings, S. & van Bergen, J., 1 Jun 2022, In: Sexually transmitted infections. 98, 4, p. 262-268 055109.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Factors Associated With the Intention to Use HIV Preexposure Prophylaxis for Young and Older Men Who Have Sex With Men

    Hulstein, S. H., Zimmermann, H. M. L., de la Court, F., Matser, A. A., Schim van der Loeff, M. F., Hoornenborg, E., Davidovich, U., Prins, M. & de Vries, H. J. C., 1 May 2022, In: Sexually transmitted diseases. 49, 5, p. 343-352 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Macrolide-Resistant Mycoplasma genitalium Impairs Clinical Improvement of Male Urethritis After Empirical Treatment

    Braam, J. F., van Dam, A. P., Bruisten, S. M., van Rooijen, M. S., de Vries, H. J. C., Schim van der Loeff, M. F. & Vergunst, C. E., 1 May 2022, In: Sexually transmitted diseases. 49, 5, p. 360-367 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial

    de Vries, H. J. C., de Laat, M., Jongen, V. W., Heijman, T., Wind, C. M., Boyd, A., de Korne-Elenbaas, J., van Dam, A. P., Schim van der Loeff, M. F., NABOGO steering group, Bruisten, S., Hoornenborg, E., Knol, M., Mathôt, R. A. A. & Prins, J. M., May 2022, In: The Lancet Infectious Diseases. 22, 5, p. 706-717 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. Does Previous Syphilis Alter the Course of Subsequent Episodes of Syphilis?

    Schim van der Loeff, M. F., Zondag, H. L., Bruisten, S. & Jongen, V. W., 15 Apr 2022, In: Clinical infectious diseases. 74, 8, p. 1503 1 p.

    Research output: Contribution to journalEditorialAcademicpeer-review

  8. Self-reported symptoms as predictors of SARS-CoV-2 infection in the general population living in the Amsterdam region, the Netherlands

    Bosdriesz, J. R., Ritsema, F., Leenstra, T., Petrignani, M. W. F., Bruisten, S. M., Coyer, L., Schreijer, A. J. M., van Duijnhoven, Y. T. H. P., Schim van der Loeff, M. F. & Matser, A. A., 1 Jan 2022, In: PLoS ONE. 17, 1 January, e0262287.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study

    Jongen, V. W., Zimmermann, H. M. L., Goedhart, M., Bogaards, J. A., Davidovich, U., Coyer, L., The Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative, de Vries, H. J. C., Prins, M., Hoornenborg, E. & van der Loeff, M. F. S., 2022, (E-pub ahead of print) In: Sexually transmitted infections.

    Research output: Contribution to journalArticleAcademicpeer-review

ID: 14325923